RT Journal Article
SR Electronic
T1 Outcomes to first-line pembrolizumab in patients with PD-L1-high (≥50%) non–small cell lung cancer and a poor performance status
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e001007
DO 10.1136/jitc-2020-001007
VO 8
IS 2
A1 Alessi, Joao V
A1 Ricciuti, Biagio
A1 Jiménez-Aguilar, Elizabeth
A1 Hong, Fangxin
A1 Wei, Zihan
A1 Nishino, Mizuki
A1 Plodkowski, Andrew J
A1 Sawan, Peter
A1 Luo, Jia
A1 Rizvi, Hira
A1 Carter, Brett W
A1 Heymach, John V
A1 Altan, Mehmet
A1 Hellmann, Matthew
A1 Awad, Mark
YR 2020
UL http://jitc.bmj.com/content/8/2/e001007.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.